Rb2/p130 gene pinpoints early prostate cancer:
This article was originally published in Clinica
Executive Summary
The progressive lack of the tumour suppresser gene Rb2/p130 could be an early indicator of prostate cancer, according to a US study in the June issue of Clinical Cancer Research. "The [study's] results indicate that this gene demonstrates a lower expression in the prostate as it progresses from normal to cancerous," said researcher Dr Antonio Giordano, of Temple University, in Philadelphia, Pennsylvania.